• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Managed Care Minute: January 31, 2015

Video

A one-minute look back at the week of January 26, 2015, in managed care, including anticipated moves from volume-based to value-based payments and expected push back on cancer drug costs.

This week HHS announced goals and a timeline for shifting Medicare payments from volume to value. Shortly after, a new task force of payers and providers formed to facilitate the transition away from fee-for-service payments.

Novartis reported that it expects payers will begin to push back against cancer drug therapy costs.

And lastly, the Joslin Diabetes Center is partnering with The American Journal of Managed Care to bring to life Patient-Centered Diabetes Care in Boston, Massachusetts, April 16-17.

Related Videos
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Eleanor Perfetto, PhD
Tom Kim, chief medical officer, Sound Long-Term Care Management
Ciara Zachary, PhD, MPH
William Schpero, PhD, MPhil, MPH
Jonathan Strober, MD, Benioff Children's Hospital
Adam Brufsky, MD, PhD
Related Content
Flat Medicare Advantage payments in 2027 may push higher costs and fewer benefits onto seniors despite CMS reforms. | Image Credit: Postmodern Studio - stock.adobe.com.jpeg

CMS Proposes Nearly Flat 2027 Medicare Advantage Payment Rates

January 27th 2026
Article

CMS’s 2027 proposed MA payment rate increase of .09% falls short of expectations, potentially increasing premiums and reducing benefits for seniors.

Read More

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

January 20th 2026
Podcast

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Listen

Socioeconomic and demographic factors were associated with variations in surgical outcomes among patients with upper extremity soft tissue sarcoma. | Image credit: @syahrir-adobestock.jpeg

Socioeconomic Factors Linked to Surgical Outcomes in Upper Extremity Soft Tissue Sarcoma

January 22nd 2026
Article

Socioeconomic and demographic factors influenced amputation and recurrence rates in upper extremity soft tissue sarcoma.

Read More

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

January 1st 2026
Podcast

Sachin H. Jain, MD, MBA, discusses 2026 health care predictions, including AI adoption, GLP-1 demand, MAHA growth, DEI’s return, and policy shifts.

Listen

As ACA subsidy extensions face uncertainty, ICHRAs are gaining attention. Here’s what employers and employees should know. | Image credit: @dragonstock_AdobeStock.jpeg

5 FAQs About ICHRAs: What to Know as ACA Subsidy Extensions Stall

January 16th 2026
Article

With ACA subsidies in limbo, ICHRAs may reshape how Americans access coverage. Here are 5 FAQs explaining what they are, who benefits, and key trade-offs.

Read More

President Trump’s proposed Great Healthcare Plan promises to lower health care costs for Americans if Congress enacts it. | Image credit: Rawf8 - stock.adobe.com

Trump Announces “The Great Healthcare Plan,” Proposing Direct Payments, Price Transparency, Insurance Reform

January 15th 2026
Article

Trump's Great Healthcare Plan aims to lower drug prices, reduce insurance premiums, and enhance transparency, according to the White House.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.